ibuprofen has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boardman, LA; Greenspan, EJ; Madigan, JP; Rosenberg, DW | 1 |
| Bartels, LE; Komninou, D; LaComb, JF; Mackenzie, GG; Mattheolabakis, G; Rigas, B; Vaeth, BM; Wang, R; Zhi, J | 1 |
2 other study(ies) available for ibuprofen and cyclin d1
| Article | Year |
|---|---|
Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}.
Topics: Adenoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta Catenin; Blotting, Western; Cell Nucleus; Colonic Neoplasms; Cyclin D1; Female; Fluorescent Antibody Technique; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Ibuprofen; Immunoenzyme Techniques; Male; Middle Aged; NF-kappa B; Phosphorylation; Signal Transduction; Tumor Cells, Cultured; Wnt Proteins | 2011 |
The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cyclin D1; Glioblastoma; Ibuprofen; Mice | 2016 |